P3I
CL icon

Progeny 3 Inc’s Colgate-Palmolive CL Stock Holding History

Progeny 3 Inc’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,040
Closed -$392K – 10
2014
Q1 		$392K Buy
+6,040
New +$381K 0.36% 30
2013
Q3 		– Sell
-12,840
Closed -$736K – 38
2013
Q2 		$736K Buy
+12,840
New +$762K 0.43% 27

Other funds holding CL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Progeny 3 Inc's CL Position: Q2 2014 in Review

Progeny 3 Inc sold out of Colgate-Palmolive (CL) in Q2 2014, closing a stake of 6,040 shares — an estimated $392K sold.

Progeny 3 Inc first reported a position in CL in Q2 2013 and held it in 2 quarters. The position peaked at $736K in Q2 2013. 1,192 funds tracked by Wall St. Rank hold CL as of Q2 2014.

  • Progeny 3 Inc reported no remaining Colgate-Palmolive position as of Q2 2014 after selling out during the quarter.
  • Progeny 3 Inc sold 6,040 Colgate-Palmolive shares in Q2 2014, an estimated $392K.
  • Progeny 3 Inc first reported a position in Colgate-Palmolive in Q2 2013 and held it in 2 quarters.
  • Progeny 3 Inc's Colgate-Palmolive position peaked at $736K in Q2 2013.
  • 1,192 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2014.

Based on Progeny 3 Inc's 13F filing for Q2 2014, filed 14 Aug 2014.